CheckMyRecalls

Hikma Pharmaceuticals USA INC recalls Alendronate Sodium Oral Solution

Published
6 May 2026
Units affected
4 single dose 75 ml bottles
Agency
FDA
Country
United States

The hazard

This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr. by: Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922, NDC 0054-0282-59.

Brand / company
Hikma Pharmaceuticals USA INC
Codes / lots
Lot # AC2040A, Exp Date: 04/2026
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 6 May 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.